Νότια Αφρική - Αγγλικά - South African Health Products Regulatory Authority (SAHPRA)

bayer (pty) ltd û isando - tablet - see ingredients - each pack contains drospirenone 3,0 mg ethinylestradiol 0,02 mg

Νότια Αφρική - Αγγλικά - South African Health Products Regulatory Authority (SAHPRA)

bayer (pty) ltd û isando - tablet - see ingredients - each tablet contains drospirenone 3,0 mg ethinylestradiol 0,02 mg levomefolate calcium 0,451 mg

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - (tablet core, product) drospirenone; (tablet core, product) ethinylestradiol betadex clathrate - tablet, film coated - 3.000 mg - (tablet core, product) drospirenone 3.000 mg; (tablet core, product) ethinylestradiol betadex clathrate 0.020 mg

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals ltd - triamterene, hydrochlorothiazide - tablets - 50mg/25mg milligram - low-ceiling diuretics and potassium-sparing agents

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

glaxosmithkline llc - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), triamterene (unii: ws821z52lq) (triamterene - unii:ws821z52lq) - hydrochlorothiazide 25 mg - this fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked. dyazide is indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone. dyazide is also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked. dyazide may be used alone or as an adjunct to other antihypertensive drugs, such as beta-blockers. since dyazide may enhance the action of these agents, dosage adjustments may be necessary. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical conseque

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

mckesson rxpak inc - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), triamterene (unii: ws821z52lq) (triamterene - unii:ws821z52lq) - hydrochlorothiazide 25 mg - this fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked. dyazide is indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone. dyazide is also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked. dyazide may be used alone or as an adjunct to other antihypertensive drugs, such as beta-blockers. since dyazide may enhance the action of these agents, dosage adjustments may be necessary. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical conseque

Μάλτα - Αγγλικά - Medicines Authority

bayer plc - drospirenone 3 mg, ethinylestradiol 0.02 mg - film-coated tablet

Μάλτα - Αγγλικά - Medicines Authority

bayer limited 1st floor the grange offices the grange brewery road stillorgan co. dublin, a94 h2k7 , ireland - drospirenone, ethinylestradiol - film-coated tablet - drospirenone 3 mg ethinylestradiol 0.02 mg - sex hormones and modulators of the genital system

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

bayer limited - ethinylestradiol; drospirenone - film-coated tablet - 0.02 mg/3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol

Καναδάς - Αγγλικά - Health Canada

bayer inc - drospirenone; ethinyl estradiol - tablet - 3mg; 0.02mg - drospirenone 3mg; ethinyl estradiol 0.02mg - contraceptives